Anti-Atezolizumab Polyclonal Antibody
Product Specifications
Background
Atezolizumab with trade name Tecentriq, is an FDA-approved drug, which is a humanized programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma or metastatic non-small cell lung cancer.
Host
Rabbit
Immunogen
Atezolizumab
Target
Rabbit polyclonal to Tecentriq.
Clonality
Polyclonal
Applications
ELISA
Purification
Purified by antigen affinity column.
Form
Liquid
Buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Storage Conditions
The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.
Notes
Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only.
Specificity
The product is specific for Atezolizumab. This antibody serves as an excellent positive control for Atezolizumab immunogenicity (ADA) assays.
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ADC-W-1531 1 mg
Anti-LOXL2 (Simtuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC
Sign In for Pricing
View Details 